Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TTRXTTRX
3 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TURN THERAPEUTICS INC

Yes. Geode Capital Management holds 17,142 shares of TTRX (Turn Therapeutics), worth $125,136, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Geode Capital Management has held TTRX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$125,136

Current Shares

17,142

Total Value Change

+$57,597

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
17,142
0.0%
$125,1360.0%$7.30
0
2026-Q1
Unchanged
17,142
0.0%
$54,8540.0%$3.20
0
2025-Q4
New
17,142
-
$67,5390.0%$3.94
32

Other major holders of TTRX: IEQ CAPITAL, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used